Related Experiment Videos
[Autonomic neuropathy in reduced glucose tolerance]
Minerva Medica
|May 12, 1985
Summary
Impaired glucose tolerance (IGT) subjects show early signs of cardiovascular autonomic neuropathy, particularly affecting parasympathetic function. These subclinical changes highlight IGT as a risk factor, similar to diabetic neuropathy.
Area of Science:
- Cardiology
- Endocrinology
- Neurology
Context:
- Investigating cardiovascular autonomic function in individuals with Impaired Glucose Tolerance (IGT).
- Utilizing standard autonomic function tests to assess sympathetic and parasympathetic innervation.
- Controlled ambulatory setting for subject monitoring.
Purpose:
- To evaluate the integrity of cardiovascular autonomic innervation in IGT subjects.
- To determine if subclinical autonomic dysfunction is present in IGT.
- To correlate autonomic dysfunction with glucose metabolism alterations.
Summary:
- 33 IGT subjects were assessed for cardiovascular autonomic innervation using standard tests.
- Pathological and borderline results were observed in specific parasympathetic function tests (SL1, SL2, LS).
- Autonomic dysfunction in IGT subjects is linked to glucose metabolism, not other factors like age or weight.
Impact:
- Identifies IGT as a high-risk population for cardiovascular autonomic neuropathy.
- Suggests early screening for autonomic dysfunction in IGT individuals.
- Emphasizes the need for proactive management in pre-diabetic states.